[1]GARCIA-TSAO G, ABRALDES JG, BERZIGOTTI A, et al.Portal hypertensive bleeding in cirrhosis:Risk stratification, diagnosis, and management:2016 practice guidance by the A-merican Association for the study of liver diseases[J].Hepatology, 2017, 65 (1) :310-335.
|
[2]de FRANCHIS R.Expanding consensus in portal hypertension:Report of the Baveno VI Consensus Workshop:Stratifying risk and individualizing care for portal hypertension[J].J Hepatol, 2015, 63 (3) :743-752.
|
[3]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Endoscopy, Chinese Medical Association.Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension[J].J Clin Hepatol, 2016, 32 (2) :203-219. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血防治指南[J].临床肝胆病杂志, 2016, 32 (2) :203-219.
|
[4]European Association for the Study of the Liver.EASL Clinical Practice Guidelines:Vascular diseases of the liver[J].J Hepatol, 2016, 64 (1) :179-202.
|
[5]MARTNLLAHM, ALBILLOS A, BAARES R, et al.Vascular diseases of the liver.Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver[J].Gastroenterol Hepatol, 2017, 40 (8) :538-580.
|
[6]KHANNA R, SARIN SK.Idiopathic portal hypertension and extrahepatic portal venous obstruction[J].Hepatol Int, 2018, 12 (Suppl 1) :148-167.
|
[7]THOMPSON RJ, TAYLOR MA, MCKIE LD, et al.Sinistral portal hypertension[J].Ulster Med J, 2006, 75 (3) :175-177.
|
[8]BOSCH J, ABRALDES JG, BERZIGOTTI A, et al.The clinical use of HVPG measurements in chronic liver disease[J].Nat Rev Gastroenterol Hepatol, 2009, 6 (10) :573-582.
|
[9]BOSCH J, IWAKIRI Y.The portal hypertension syndrome:Etiology, classification, relevance, and animal models[J].Hepatol Int, 2018, 12 (Suppl 1) :1-10.
|
[10]ZHANG M, ZHUGE YZ, ZOU XP.Application of interventional techniques in patients with unknown etiologic portal hypertension[J].JPrac Hepatol, 2018, 21 (3) :329-331. (in Chinese) 张明, 诸葛宇征, 邹晓平.介入技术在不明原因的门脉高压症诊治中的应用[J].实用肝脏病杂志, 2018, 21 (3) :329-331.
|
[11]ABRALDES JG, SARLIEVE P, TANDON P.Measurement of portal pressure[J].Clin Liver Dis, 2014, 18 (4) :779-792.
|
[12]KHANNA R, SARIN SK.Non-cirrhotic portal hypertensiondiagnosis and management[J].J Hepatol, 2014, 60 (2) :421-441.
|
[13]RAJESH S, MUKUND A, SUREKA B, et al.Non-cirrhotic portal hypertension:An imaging review[J].Abdom Radiol (NY) , 2018, 43 (8) :1991-2010.
|
[14]SAHIN A, ARTAS H, TUNC N, et al.Hematological indices in portal hypertension:Cirrhosis versus noncirrhotic portal hypertension[J].J Clin Med, 2018, 7 (8) :196.
|
[15]LIU F, NING Z, LIU Y, et al.Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701) :A prospective multicenter study[J].EBio Medicine, 2018, 36:151-158.
|
[16]TSENG Y, MA L, LUO T, et al.Non-invasive predictive model for hepatic venous pressure gradient based on a 3-dimensional computed tomography volume rendering technology[J].Exp T-her Med, 2018, 15 (4) :3329-3335.
|
[17]SHIHA G, IBRAHIM A, HELMY A, et al.Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis:A 2016 update[J].Hepatol Int, 2017, 11 (1) :1-30.
|
[18]QI X, BERZIGOTTI A, CARDENAS A, et al.Emerging noninvasive approaches for diagnosis and monitoring of portal hypertension[J].Lancet Gastroenterol Hepatol, 2018, 3 (10) :708-719.
|
[19]ZHANG J, CHEN MK.Progress of diagnosis and treatment of portal hypertension[J].Chin J Gastroenterol Hepatol, 2018, 27 (3) :341-345. (in Chinese) 张静, 陈明锴.门脉高压症的诊断与治疗进展[J].胃肠病学和肝病学杂志, 2018, 27 (3) :341-345.
|
[20]QI X.Virtual portal pressure gradient from anatomic CT angiography[J].Gut, 2015, 64 (6) :1004-1005.
|
[21]GIOIA S, NARDELLI S, PASQUALE C, et al.Natural history of patients with non cirrhotic portal hypertension:Comparison with patients with compensated cirrhosis[J].Dig Liver Dis, 2018, 50 (8) :839-844.
|
[22]Chinese Portal Hypertension Diagnosis and Monitoring Study Group (Chess) ;Minimally Invasive Intervention Collaborative Group, Chinese Society of Gastroenterology;Emergency Intervention Committee, Chinese Society of Interventionalists, et al.Consensus on clinical applictation of hepatic venous pressure gradient in China (2018) [J].J Clin Hepatol, 2018, 34 (12) :2526-2536. (in Chinese) 中国门静脉高压诊断与监测研究组 (CHESS) , 中华医学会消化病学分会微创介入协作组, 中国医师协会介入医师分会急诊介入专业委员会, 等.中国肝静脉压力梯度临床应用专家共识 (2018版) [J].临床肝胆病杂志, 2018, 34 (12) :2526-2536.
|
[23]CHEN SY, HUANG XQ, CENG XQ.Etiology and diagnosis of portal hypertension[J].J Pract Hepatol, 2018, 21 (3) :321-324. (in Chinese) 陈世耀, 黄晓铨, 曾晓清.门脉高压症的检查选择与病因诊断[J].实用肝脏病杂志, 2018, 21 (3) :321-324.
|
[24]TRIPATHI D, STANLEY AJ, HAYES PC, et al.UK guidelines on the management of variceal haemorrhage in cirrhotic patients[J].Gut, 2015, 64 (11) :1680-1704.
|
[25] GARCA-PAGN JC, CACA K, BUREAU C, et al.Early use of TIPS in patients with cirrhosis and variceal bleeding[J].NEngl J Med, 2010, 153 (10) :2370-2379.
|
[26]SAUERBRUCH T, SCHIERWAGEN R, TREBICKA J.Managing portal hypertension in patients with liver cirrhosis[J].F1000Res, 2018, 7:533.
|
[27]SCHWABL P, LALEMAN W.Novel treatment options for portal hypertension[J].Gastroenterol Rep, 2017, 5 (2) :90-103.
|